Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Bora Pharmaceuticals Revenue

Bora Pharmaceuticals had revenue of 4.00B TWD in the quarter ending March 31, 2026, a decrease of -10.68%. This brings the company's revenue in the last twelve months to 18.54B, down -2.69% year-over-year. In the year 2025, Bora Pharmaceuticals had annual revenue of 19.01B with 9.11% growth.

• Revenue (ttm): 18.54B
• Revenue Growth: -2.69%
• P/S Ratio: 2.37
• Revenue / Employee: n/a
• Employees: 36
• Market Cap: 43.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.01B	1.59B	9.11%
Dec 31, 2024	17.43B	3.23B	22.72%
Dec 31, 2023	14.20B	3.71B	35.31%
Dec 31, 2022	10.49B	5.59B	114.18%
Dec 31, 2021	4.90B	3.10B	172.28%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error